Loading resource…

KDIGO
This supplement to the KDIGO 2026 Clinical Practice Guideline focuses on the comprehensive management of anemia in individuals with Chronic Kidney Disease (CKD). It covers the diagnosis and evaluation of anemia, the use of iron therapy for iron deficiency and anemia, and the application of erythropoiesis-stimulating agents (ESAs), hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), and other agents. Additionally, it addresses the role of red blood cell transfusions in treating anemia within this patient population. The guideline development methods and relevant supplementary materials are also included.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology

Integrated CKD Management Guidelines for Uganda
Same clinical topic · Nephrology

KDIGO 2026 CLINICAL PRACTICE GUIDELINE FOR DIABETES AND CHAPTER 1, CHAPTER 2, & CHAPTER 4 UPDATE DRAFT
Same clinical topic · Nephrology

KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology

KDIGO-2024-CKD-Guideline
Same clinical topic · Nephrology

DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE: SYNOPSIS OF THE KDIGO 2022 CLINICAL PRACTICE GUIDELINE UPDATE
Same clinical topic · Nephrology

KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS
Same clinical topic · Nephrology

KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease
Same clinical topic · Nephrology

TREATMENT OF HYPERKALEMIA IN ADULTS
Same clinical topic · Nephrology